Precigen Inc (PGEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -250,642 | -126,235 | -95,904 | 28,317 | -92,166 |
| Depreciation Amortization | 5,257 | 11,052 | 15,309 | 13,121 | 26,728 |
| Income taxes - deferred | N/A | -1,795 | -479 | -150 | -167 |
| Accounts receivable | -3,199 | 414 | 12,229 | -13,513 | -6,560 |
| Accounts payable and accrued liabilities | 8,768 | 1,549 | -2,421 | 379 | 420 |
| Other Working Capital | 6,624 | 2,661 | 3,396 | -22,699 | -804 |
| Other Operating Activity | 145,361 | 44,181 | 940 | -70,500 | 16,778 |
| Operating Cash Flow | $-87,831 | $-68,173 | $-66,930 | $-65,045 | $-55,771 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -208,006 | -187,206 | -185,026 | 0 | -170,467 |
| PPE Investments | -1,995 | -8,524 | -1,438 | -4,330 | -4,241 |
| Sale Of Investment | 208,466 | 175,016 | 183,377 | 68,441 | 100,168 |
| Other Investing Activity | 0 | 0 | 0 | 162,306 | 0 |
| Investing Cash Flow | $-1,535 | $-20,714 | $-3,087 | $226,417 | $-74,540 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 92,818 | 0 | 0 | N/A | N/A |
| Debt Repayment | N/A | N/A | -43,219 | -155,293 | -466 |
| Common Stock Issued | 847 | 31,583 | 72,808 | 1 | 121,653 |
| Other Financing Activity | -3,617 | 79,000 | 0 | 0 | 0 |
| Financing Cash Flow | $90,048 | $110,583 | $29,589 | $-155,292 | $121,187 |
| Exchange Rate Effect | 35 | -27 | -320 | -827 | 217 |
| Beginning Cash Position | 29,517 | 7,848 | 48,596 | 43,343 | 52,250 |
| End Cash Position | 30,234 | 29,517 | 7,848 | 48,596 | 43,343 |
| Net Cash Flow | $717 | $21,669 | $-40,748 | $5,253 | $-8,907 |
| Free Cash Flow | |||||
| Operating Cash Flow | -87,831 | -68,173 | -66,930 | -65,045 | -55,771 |
| Capital Expenditure | -1,995 | -8,584 | -1,536 | -4,924 | -7,247 |
| Free Cash Flow | -89,826 | -76,757 | -68,466 | -69,969 | -63,018 |